Advanced gastric cancer and colorectal cancer
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Henan University of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged >= 18 years, men and women; 2. Patients with advanced gastric cancer and colorectal cancer diagnosed by histology or cytology; 3. At least measurable lesions (according to recist1.1, the long diameter of spiral CT scanning of measurable lesions is >= 10mm or the short diameter of enlarged lymph nodes is >= 15mm); 4. The investigator determined that the patient could receive carrelizumab; 5. Voluntarily join the study, sign the informed consent form, have good compliance and cooperate with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Allergic to carrelizumab and its excipients; 3. Patients currently participating in other clinical studies; 4. The researcher judges other situations that are not suitable for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| progression-free survival;time to disease progression;6-month OS rate, 1-year OS rate, 2-year OS rate;objective response rate;disease control rate;adverse event; | — |
Countries
China
Contacts
Public ContactGuo Yanzhen, Chen Ye
The First Affiliated Hospital of He'nan University of Science and Technology
Outcome results
None listed